SCHEMBL7169265

SCHEMBL7169265

CCOC(=O)C1CCC(c2ccccc2)=N1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.51
ALDH1A1 P00352 4/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
KDM4E B2RXH2 3/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
CASP3 P42574 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43
TSHR P16473 1/20 0.42
ATM Q13315 1/20 0.42
NPC1 O15118 2/20 0.41
HSD17B10 Q99714 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
CHRM2 P08172 1/20 0.41
CHRM4 P08173 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20835448 1.00 RAB9A (0.51) RAB9AALDH1A1SMN1; SMN2KDM4EL3MBTL1
SCHEMBL2584740 0.86 LMNA (0.53) ALDH1A1SMN1; SMN2TSHRMEN1KMT2A
SCHEMBL22040222 0.86 NR3C2 (0.43) RAB9AALDH1A1KDM4EL3MBTL1TSHR
SCHEMBL3625341 0.86 LMNA (0.53) ALDH1A1SMN1; SMN2TSHRMEN1KMT2A
SCHEMBL13311119 0.86 MAPT (0.50) ALDH1A1L3MBTL1MAPTLMNA
SCHEMBL483661 0.86 MAPT (0.50) ALDH1A1L3MBTL1MAPTLMNA
SCHEMBL5153442 0.84 TSHR (0.43) RAB9AALDH1A1SMN1; SMN2L3MBTL1TSHR
SCHEMBL2586557 0.84 TRPM8 (0.46) ALDH1A1SMN1; SMN2KDM4EL3MBTL1HSD17B10
SCHEMBL2584512 0.84 TRPM8 (0.46) RAB9AALDH1A1KDM4ETSHRATM
SCHEMBL22546653 0.84 DGAT2 (0.44) RAB9AALDH1A1SMN1; SMN2L3MBTL1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013033310-A1 MODULATORS OF REV-ERB KAMENECKA THEODORE MARK (US) 2013-03-07 WO disclosed
EP-1083897-A4 HIV INTEGRASE INHIBITORS MERCK & CO INC (US) 2003-01-02 EP disclosed
EP-1083897-A1 HIV INTEGRASE INHIBITORS Merck & Co., Inc. (US) 2001-03-21 EP disclosed
WO-1999062513-A1 HIV INTEGRASE INHIBITORS MERCK & CO., INC. (US) 1999-12-09 WO disclosed